Post hoc analysis reports efficacy and safety of ozanimod in Japanese patients, suggesting its potential as a treatment option.
No takes yet. Share an insight, caveat, or question.
Hisamatsu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: